Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The major hypothesis to be tested is that there was no difference in the clinical outcome between 7(short-course) and 14(traditional-course) days of antibiotic treatment for asymptomatic bacteriuria early after kidney transplantation.
Introduction: Treatment of asymptomatic bacteriuria is a common practice in renal transplant centers leading to prolong exposure of antimicrobial agents with long hospital length of stay. The duration of antibiotics treatment in this condition have never been proposed.
Objective: To evaluate the proper duration of antibiotic treatment for asymptomatic bacteriuria early (less than 1 month) after kidney transplantation
Method: This is a prospective, randomized, open labeled, single center study using intention to treat analysis. Patients will be identified and after informed consent is obtained, will be randomized to receive 7 or 14 days course of antibiotics.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 7 days course of antibiotic treatment | Experimental | To assign the 7 days course of antibiotic treatment, start specific intravenous antibiotic therapy as microbiological susceptibility from urine culture |
|
| 14 days course of antibiotic treatment | Active Comparator | To assign the 14 days course of antibiotic treatment, start specific intravenous antibiotic therapy as microbiological susceptibility from urine culture |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 7 days course of antibiotic treatment | Drug | start specific intravenous antibiotic therapy as microbiological susceptibility from urine culture for 7 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite end point of Symptomatic urinary tract infection, Sepsis, Graft function and Mortality rate | Composite end point at 1 month after discontinuing antibiotics | 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Composite end point of Symptomatic urinary tract infection, Sepsis, Graft function and Mortality rate | Composite end point at 0.5 months after discontinuing antibiotics | 0.5 months |
| Composite end point of Symptomatic urinary tract infection, Sepsis, Graft function and |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pattraporn Ponglorpisit, MD | Ramathibodi Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pattraporn Ponglorpisit | Ratchathewi | Bangkok | 10400 | Thailand |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 14 days course of antibiotic treatment | Drug | start specific intravenous antibiotic therapy as microbiological susceptibility from urine culture for 14 days |
|
|
Composite end point at 3 months after discontinuing antibiotics |
| 3 months |
| duration of hospital stay | duration of hospital stay | 30 days since randomization |
| ID | Term |
|---|---|
| D001437 | Bacteriuria |
| D058345 | Asymptomatic Infections |
| ID | Term |
|---|---|
| D014552 | Urinary Tract Infections |
| D007239 | Infections |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D058070 | Asymptomatic Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided